SER: Serina Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Serina Therapeutics Inc (SER).
$44.55M Market Cap.
SER Market Cap. (MRY)
SER Shares Outstanding (MRY)
SER Assets (MRY)
Total Assets
$6.72M
Total Liabilities
$6.22M
Total Investments
$0
SER Income (MRY)
Revenue
$56.00K
Net Income
-$11.14M
Operating Expense
$17.10M
SER Cash Flow (MRY)
CF Operations
-$17.14M
CF Investing
-$22.00K
CF Financing
$13.21M
SER Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Total Assets | $6,724,000 (-25.02%) | $8,968,000 (945.17%) | $858,042 (-72.80%) | $3,154,000 (-19.64%) |
Assets Current | $5,676,000 (-25.50%) | $7,619,000 (1288.87%) | $548,575 (-75.44%) | $2,234,000 (-2.15%) |
Assets Non-Current | $1,048,000 (-22.31%) | $1,349,000 (335.91%) | $309,467 (-66.36%) | $920,000 (-43.97%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $870,000 (-45.35%) |
Shareholders Equity | $641,000 (101.98%) | -$32,294,000 (14.52%) | -$37,778,161 (-219.29%) | -$11,832,000 (-131.27%) |
Property Plant & Equipment Net | $1,048,000 (-22.31%) | $1,349,000 (335.91%) | $309,467 (0%) | $0 (0%) |
Cash & Equivalents | $3,672,000 (-51.80%) | $7,619,000 (1331.53%) | $532,229 (-16.05%) | $634,000 (20.30%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $153,500 (0%) | $0 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $25,000 (-92.33%) |
Trade & Non-Trade Payables | $744,000 (28.28%) | $580,000 (304.64%) | $143,337 (-82.96%) | $841,000 (-51.30%) |
Accumulated Retained Earnings (Deficit) | -$44,318,000 (-33.58%) | -$33,177,000 (13.71%) | -$38,446,482 (63.64%) | -$105,748,000 (-8.94%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $268,000 (-92.22%) | $3,445,000 (89.89%) | $1,814,175 (-86.26%) | $13,202,000 (109.69%) |
Debt Current | $0 (0%) | $0 (0%) | $133,924 (-98.12%) | $7,140,000 (198.00%) |
Debt Non-Current | $268,000 (-92.22%) | $3,445,000 (105.03%) | $1,680,251 (-72.28%) | $6,062,000 (55.44%) |
Total Liabilities | $6,216,000 (27.95%) | $4,858,000 (52.06%) | $3,194,703 (-78.74%) | $15,029,000 (61.24%) |
Liabilities Current | $2,366,000 (67.45%) | $1,413,000 (222.83%) | $437,686 (-95.12%) | $8,967,000 (67.39%) |
Liabilities Non-Current | $3,850,000 (11.76%) | $3,445,000 (24.95%) | $2,757,017 (-54.52%) | $6,062,000 (52.93%) |
SER Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Revenues | $56,000 (-98.22%) | $3,153,000 (433.05%) | $591,500 (310.76%) | $144,000 (-60.11%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $19,000 (-26.92%) |
Selling General & Administrative Expense | $9,624,000 (147.15%) | $3,894,000 (202.15%) | $1,288,783 (-80.79%) | $6,708,000 (-0.19%) |
Research & Development Expense | $7,480,000 (213.23%) | $2,388,000 (51.80%) | $1,573,085 (8.04%) | $1,456,000 (-60.80%) |
Operating Expenses | $17,104,000 (172.27%) | $6,282,000 (119.51%) | $2,861,868 (-62.39%) | $7,610,000 (-26.33%) |
Interest Expense | $526,000 (-5.73%) | $558,000 (3414.30%) | $15,878 (-98.55%) | $1,097,000 (171.53%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $103,000 (-82.15%) |
Consolidated Income | -$11,207,000 (-312.70%) | $5,269,000 (296.45%) | -$2,682,108 (69.12%) | -$8,685,000 (20.87%) |
Net Income to Non-Controlling Interests | -$66,000 (0%) | $0 (0%) | $0 (0%) | -$10,000 (90.99%) |
Net Income | -$11,141,000 (-311.44%) | $5,269,000 (296.45%) | -$2,682,108 (69.08%) | -$8,675,000 (20.16%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$11,141,000 (-311.44%) | $5,269,000 (296.45%) | -$2,682,108 (69.08%) | -$8,675,000 (20.16%) |
Weighted Average Shares | $7,359,000 (229.26%) | $2,235,000 (4.20%) | $2,145,002 (99.12%) | $1,077,225 (0.58%) |
Weighted Average Shares Diluted | $7,359,000 (0.11%) | $7,351,000 (242.70%) | $2,145,002 (99.12%) | $1,077,225 (0.58%) |
Earning Before Interest & Taxes (EBIT) | -$10,615,000 (-282.17%) | $5,827,000 (318.55%) | -$2,666,230 (64.82%) | -$7,578,000 (27.56%) |
Gross Profit | $56,000 (-98.22%) | $3,153,000 (433.05%) | $591,500 (373.20%) | $125,000 (-62.69%) |
Operating Income | -$17,048,000 (-444.84%) | -$3,129,000 (-37.82%) | -$2,270,368 (69.67%) | -$7,485,000 (25.11%) |
SER Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Net Cash Flow from Investing | -$22,000 (95.63%) | -$504,000 (-151.38%) | $980,937 (47.29%) | $666,000 (3430.00%) |
Net Cash Flow from Financing | $13,212,000 (31.24%) | $10,067,000 (667.26%) | $1,312,070 (-81.89%) | $7,246,000 (21.56%) |
Net Cash Flow from Operations | -$17,137,000 (-592.12%) | -$2,476,000 (-19.29%) | -$2,075,624 (73.58%) | -$7,855,000 (-0.49%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$3,947,000 (-155.69%) | $7,087,000 (3160.14%) | $217,383 (281.37%) | $57,000 (103.04%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $416,000 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $990,619 (296.25%) | $250,000 (0%) |
Capital Expenditure | -$22,000 (95.63%) | -$504,000 (-5105.54%) | -$9,682 (0%) | $0 (0%) |
Issuance (Repayment) of Debt Securities | $2,875,000 (-71.40%) | $10,052,000 (668.71%) | $1,307,648 (-80.63%) | $6,750,000 (10.33%) |
Issuance (Purchase) of Equity Shares | $5,012,000 (33313.33%) | $15,000 (239.21%) | $4,422 (-99.11%) | $496,000 (0%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $2,595,000 (10280.00%) | $25,000 (251.62%) | $7,110 (-99.29%) | $999,000 (9.90%) |
Depreciation Amortization & Accretion | $421,000 (59.47%) | $264,000 (24.95%) | $211,284 (61.29%) | $131,000 (-89.56%) |
SER Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Gross Margin | 100.00% (0.00%) | 100.00% (0.00%) | 100.00% (15.21%) | 86.80% (-6.47%) |
Profit Margin | -19894.60% (-12005.80%) | 167.10% (136.85%) | -453.40% (92.47%) | -6024.30% (-100.16%) |
EBITDA Margin | -18203.60% (-9522.15%) | 193.20% (146.55%) | -415.00% (91.98%) | -5171.50% (-102.80%) |
Return on Average Equity (ROAE) | 131.80% (736.71%) | -20.70% (-250.00%) | 13.80% (-85.65%) | 96.20% (-73.55%) |
Return on Average Assets (ROAA) | -124.70% (-372.27%) | 45.80% (134.83%) | -131.50% (57.25%) | -307.60% (-27.21%) |
Return on Sales (ROS) | -18955.40% (-10357.25%) | 184.80% (140.99%) | -450.80% (91.43%) | -5262.50% (-81.60%) |
Return on Invested Capital (ROIC) | -992.30% (-2329.89%) | 44.50% (171.20%) | -62.50% (56.42%) | -143.40% (83.12%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -3.32 (-157.84%) | 5.74 (136.95%) | -15.53 (-227.66%) | -4.74 (9.60%) |
Price to Sales Ratio (P/S) | 658.37 (6759.43%) | 9.6 (-86.36%) | 70.39 (-75.46%) | 286.78 (80.81%) |
Price to Book Ratio (P/B) | 69.5 (15475.88%) | -0.45 (18.41%) | -0.55 (84.15%) | -3.5 (68.79%) |
Debt to Equity Ratio (D/E) | 9.7 (6564.67%) | -0.15 (-76.47%) | -0.09 (93.31%) | -1.27 (30.30%) |
Earnings Per Share (EPS) | -1.51 (-163.98%) | 2.36 (288.80%) | -1.25 (84.55%) | -8.09 (20.69%) |
Sales Per Share (SPS) | 0.01 (-99.43%) | 1.41 (411.23%) | 0.28 (105.97%) | 0.13 (-60.24%) |
Free Cash Flow Per Share (FCFPS) | -2.33 (-74.94%) | -1.33 (-37.14%) | -0.97 (86.67%) | -7.29 (0.34%) |
Book Value Per Share (BVPS) | 0.09 (100.60%) | -14.45 (17.96%) | -17.61 (-60.34%) | -10.98 (-129.94%) |
Tangible Assets Book Value Per Share (TABVPS) | 0.91 (-77.22%) | 4.01 (903.25%) | 0.4 (-81.13%) | 2.12 (-2.66%) |
Enterprise Value Over EBIT (EV/EBIT) | -5 (-266.67%) | 3 (121.43%) | -14 (-100.00%) | -7 (-16.67%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -5.18 (-292.49%) | 2.69 (118.31%) | -14.69 (-110.30%) | -6.99 (-4.24%) |
Asset Turnover | 0.01 (-97.81%) | 0.27 (-5.52%) | 0.29 (468.63%) | 0.05 (-36.25%) |
Current Ratio | 2.4 (-55.51%) | 5.39 (330.33%) | 1.25 (403.21%) | 0.25 (-41.55%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$17,159,000 (-475.81%) | -$2,980,000 (-42.90%) | -$2,085,306 (73.45%) | -$7,855,000 (-0.23%) |
Enterprise Value (EV) | $52,780,800 (222.16%) | $16,383,235 (-54.58%) | $36,073,033 (-30.67%) | $52,029,702 (-15.68%) |
Earnings Before Tax (EBT) | -$11,141,000 (-311.44%) | $5,269,000 (296.45%) | -$2,682,108 (69.08%) | -$8,675,000 (20.16%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$10,194,000 (-267.36%) | $6,091,000 (348.11%) | -$2,454,946 (67.03%) | -$7,447,000 (19.11%) |
Invested Capital | $954,000 (-71.78%) | $3,381,000 (98.61%) | $1,702,302 (-71.07%) | $5,885,000 (114.39%) |
Working Capital | $3,310,000 (-46.66%) | $6,206,000 (5496.59%) | $110,889 (101.65%) | -$6,733,000 (-119.03%) |
Tangible Asset Value | $6,724,000 (-25.02%) | $8,968,000 (945.17%) | $858,042 (-62.43%) | $2,284,000 (-2.10%) |
Market Capitalization | $44,548,800 (204.89%) | $14,611,235 (-30.23%) | $20,943,033 (-49.36%) | $41,353,702 (-27.81%) |
Average Equity | -$8,451,250 (66.82%) | -$25,474,750 (-31.23%) | -$19,411,790 (-115.20%) | -$9,020,500 (-201.94%) |
Average Assets | $8,930,750 (-22.32%) | $11,496,500 (463.48%) | $2,040,260 (-27.66%) | $2,820,500 (-37.24%) |
Invested Capital Average | $1,069,750 (-91.82%) | $13,085,500 (206.64%) | $4,267,326 (-19.26%) | $5,285,000 (329.15%) |
Shares | 8,891,976 (724.03%) | 1,079,080 (0.01%) | 1,078,964 (0.02%) | 1,078,737 (0.66%) |